In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI

This publication has 21 references indexed in Scilit:

• Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differences
  Magnetic Resonance in Medicine, 1996
• Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
  Radiology, 1996
• Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy
  Urology, 1995
• Citrate alterations in primary and metastatic human prostatic adenocarcinomas: ¹H magnetic resonance spectroscopy and biochemical study
  Magnetic Resonance in Medicine, 1993
• Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T
  Magnetic Resonance in Medicine, 1993
• Concepts of citrate production and secretion by prostate 1. Metabolic relationships
  The Prostate, 1991
• Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.
  Radiology, 1989
• Prostate epithelial cells utilize glucose and aspartate as the carbon sources for net citrate production
  The Prostate, 1989
• In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate gland by magnetic resonance imaging
  Magnetic Resonance Imaging, 1987
• Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.
  Radiology, 1986